General Information of the Protein
Protein ID
PT01807
Protein Name
Histone deacetylase 7
Secondarily
Protein Name
Histone deacetylase 7A
Gene Name
HDAC7
Secondarily
Gene Name
HDAC7A
Sequence
MDLRVGQRPPVEPPPEPTLLALQRPQRLHHHLFLAGLQQQRSVEPMRLSMDTPMPELQVGPQEQELRQLLHKDKSKRSAVASSVVKQKLAEVILKKQQAALERTVHPNSPGIPYRTLEPLETEGATRSMLSSFLPPVPSLPSDPPEHFPLRKTVSEPNLKLRYKPKKSLERRKNPLLRKESAPPSLRRRPAETLGDSSPSSSSTPASGCSSPNDSEHGPNPILGSEALLGQRLRLQETSVAPFALPTVSLLPAITLGLPAPARADSDRRTHPTLGPRGPILGSPHTPLFLPHGLEPEAGGTLPSRLQPILLLDPSGSHAPLLTVPGLGPLPFHFAQSLMTTERLSGSGLHWPLSRTRSEPLPPSATAPPPPGPMQPRLEQLKTHVQVIKRSAKPSEKPRLRQIPSAEDLETDGGGPGQVVDDGLEHRELGHGQPEARGPAPLQQHPQVLLWEQQRLAGRLPRGSTGDTVLLPLAQGGHRPLSRAQSSPAAPASLSAPEPASQARVLSSSETPARTLPFTTGLIYDSVMLKHQCSCGDNSRHPEHAGRIQSIWSRLQERGLRSQCECLRGRKASLEELQSVHSERHVLLYGTNPLSRLKLDNGKLAGLLAQRMFVMLPCGGVGVDTDTIWNELHSSNAARWAAGSVTDLAFKVASRELKNGFAVVRPPGHHADHSTAMGFCFFNSVAIACRQLQQQSKASKILIVDWDVHHGNGTQQTFYQDPSVLYISLHRHDDGNFFPGSGAVDEVGAGSGEGFNVNVAWAGGLDPPMGDPEYLAAFRIVVMPIAREFSPDLVLVSAGFDAAEGHPAPLGGYHVSAKCFGYMTQQLMNLAGGAVVLALEGGHDLTAICDASEACVAALLGNRVDPLSEEGWKQKPNLNAIRSLEAVIRVHSKYWGCMQRLASCPDSWVPRVPGADKEEVEAVTALASLSVGILAEDRPSEQLVEEEEPMNL
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Epigenetic regulator
>
Eraser
>
Histone deacetylase
>
HDAC class IIa
Function
Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Involved in muscle maturation by repressing transcription of myocyte enhancer factors such as MEF2A, MEF2B and MEF2C. During muscle differentiation, it shuttles into the cytoplasm, allowing the expression of myocyte enhancer factors (By similarity). May be involved in Epstein-Barr virus (EBV) latency, possibly by repressing the viral BZLF1 gene. Positively regulates the transcriptional repressor activity of FOXP3 (PubMed:17360565). Serves as a corepressor of RARA, causing its deacetylation and inhibition of RARE DNA element binding (PubMed:28167758). In association with RARA, plays a role in the repression of microRNA-10a and thereby in the inflammatory response (PubMed:28167758).
    Show/Hide
Uniprot ID
Primary ID:
Q8WUI4

Secondarily ID:
B3KY08
B4DWI0
B4E0Q5
Q6P1W9
Q6W9G7
Q7Z4K2
Q7Z5I1
Q96K01
Q9BR73
Q9H7L0
Q9NW41
Q9NWA9
Q9NYK9
Q9UFU7
    Show/Hide
HGNC ID
HGNC:14067
Subcellular Location
Nucleus
Cytoplasm
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000314 , HEK293T/17
Compound ID Compound Name Compound Formula
CP0431647
3,4-dichloro-N-[[4-(hydroxycarbamoyl)phenyl]methyl]benzamide
   Show/Hide
C15H12Cl2N2O3
 1
1
IC50 = 500 nM
   TI
   LI
   LO
   TS
CP0057110
4-[[butyl(phenylcarbamoyl)amino]methyl]-N-hydroxybenzamide
   Show/Hide
C19H23N3O3
 1
1
IC50 = 2430 nM
   TI
   LI
   LO
   TS
CP0431646
5-[2-[(3,4-dichlorobenzoyl)amino]ethyl]-N-hydroxy-1,2-oxazole-3-carboxamide
   Show/Hide
C13H11Cl2N3O4
 1
1
IC50 = 8340 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0003580
Faridak
   Show/Hide
C21H23N3O2
 6
1 IC50 = 8.2 nM
2 IC50 = 531 nM
3 IC50 = 4354 nM
4 Ki = 2.3 nM
5 Ki = 630 nM
6 Ki = 4550 nM
CP0003832
N'-hydroxy-N-phenyloctanediamide
   Show/Hide
C14H20N2O3
 26
1 IC50 = 21.6 nM
2 IC50 = 34.4 nM
3 IC50 = 75.2 nM
4 IC50 = 102.4 nM
5 IC50 = 344 nM
6 IC50 = 500 nM
7 IC50 = 2480 nM
8 IC50 = 6110 nM
9 IC50 = 8200 nM
10 IC50 = 9600 nM
11 IC50 = 21000 nM
12 IC50 = 29290 nM
13 IC50 = 29760 nM
14 IC50 = 38900 nM
15 IC50 = 41000 nM
16 IC50 = 41800 nM
17 IC50 = 54910 nM
18 IC50 = 61020 nM
19 IC50 > 1000 nM
20 IC50 > 5000 nM
21 IC50 > 10000 nM
22 IC50 > 30000 nM
23 IC50 > 33000 nM
24 IC50 > 33330 nM
25 Kd = 36000 nM
26 Ki = 129 nM
CP0005479
CHEBI:46024
   Show/Hide
C17H22N2O3
 10
1 IC50 = 22 nM
2 IC50 = 22.46 nM
3 IC50 = 22.5 nM
4 IC50 = 139 nM
5 IC50 = 197 nM
6 IC50 = 200 nM
7 IC50 = 2300 nM
8 IC50 = 4170 nM
9 Ki = 195 nM
10 Ki = 300 nM
CP0003676
N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide
   Show/Hide
C23H24N8O4S
 2
1 IC50 = 27 nM
2 IC50 = 426 nM
CP0033005
2-(2-fluorophenyl)-N-hydroxy-2-[4-[5-(trifluoromethyl)pyrimidin-2-yl]phenyl]acetamide
   Show/Hide
C19H13F4N3O2
 1
1 IC50 = 31 nM
CP0124688
N-hydroxy-9H-fluorene-9-carboxamide
   Show/Hide
C14H11NO2
 1
1 IC50 = 70 nM
CP0066173
N-hydroxy-2,2-diphenylacetamide
   Show/Hide
C14H13NO2
 1
1 IC50 = 650 nM
CP0057110
4-[[butyl(phenylcarbamoyl)amino]methyl]-N-hydroxybenzamide
   Show/Hide
C19H23N3O3
 1
1 IC50 = 4460 nM
CP0004988
pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate
   Show/Hide
C21H20N4O3
 3
1 IC50 > 10 nM
2 IC50 > 50000 nM
3 IC50 > 100000 nM
CP0016939
N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide
   Show/Hide
C23H20N6O
 1
1 IC50 > 10000 nM
CP0015005
S-[(E)-4-[(4Z,7S,10S)-4-ethylidene-2,5,8,12-tetraoxo-7-propan-2-yl-9-oxa-16-thia-3,6,13,18-tetrazabicyclo[13.2.1]octadeca-1(17),15(18)-dien-10-yl]but-3-enyl] octanethioate
   Show/Hide
C29H42N4O6S2
 1
1 IC50 > 10000 nM
CP0013041
HPOB
   Show/Hide
C17H18N2O4
 1
1 IC50 > 10000 nM
CP0008777
JNJ-26481585
   Show/Hide
C21H26N6O2
 2
1 Ki = 1.7 nM
2 Ki = 66.6 nM
CP0013235
(E)-3-[2-butyl-1-[2-(diethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide
   Show/Hide
C20H32Cl2N4O2
 1
1 Ki = 107 nM
CP0013905
[6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate
   Show/Hide
C24H27N3O4
 1
1 Ki = 240 nM
Clinical Information about the Protein
Target 1 ( Histone deacetylase 7 (HDAC7) )
Target Type Patented-recorded Target